The World Health Organization has approved the first malaria treatment designed for newborns, aiming to improve survival rates and strengthen global efforts against one of the deadliest infectious diseases. BulletsIn The World Health Organization has granted prequalification to artemether-lumefantrine, the first malaria drug specifically formulated for newborns and infants, marking a major global health milestone.